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Abstract
Cardiac tissue engineering will remain only a prospect unless large numbers of therapeutic cells can be pro-
vided, either from small samples of cardiac cells or from stem cell sources. In contrast to most adult cells,
cardiomyocytes are terminally differentiated and cannot be expanded in culture. We explored the feasibility of
enabling the in vitro expansion of primary neonatal rat cardiomyocytes by lentivector-mediated cell immortal-
ization, and then reverting the phenotype of the expanded cells back to the cardiomyocyte state. Primary rat
cardiomyocytes were transduced with simian virus 40 large T antigen (TAg), or with Bmi-1 followed by the
human telomerase reverse transcriptase (hTERT) gene; the cells were expanded; and the transduced genes were
removed by adenoviral vector expressing Cre recombinase. The TAg gene was more efficient in cell transduction
than the Bmi-1=hTERT gene, based on the rate of cell proliferation. Immortalized cells exhibited the morpho-
logical features of dedifferentiation (increased vimentin expression, and reduced expression of troponin I and
Nkx2.5) along with the continued expression of cardiac markers (a-actin, connexin-43, and calcium transients).
After the immortalization was reversed, cells returned to their differentiated state. This strategy for controlled
expansion of primary cardiomyocytes by gene transfer has potential for providing large amounts of a patient’s
own cardiomyocytes for cell therapy, and the cardiomyocytes derived by this method could be a useful cellular
model by which to study cardiogenesis.
Introduction
Myocardial infarction affects more than 500,000patients in the United States each year (Kirkpatrick
et al., 2007), largely because of minimal endogenous cardiac
regeneration that cannot compensate for the massive loss of
cardiomyocytes after myocardial infarction. Tissue engineer-
ing of a functional cardiac patch is being studied as a potential
way to replace damagedmyocardium. However, engineering
a clinically sized cardiac patch (centimeters in size, milli-
meters thick) requires large numbers of cells, because of the
high cell density (*108 cells=cm3) that needs to be established
for functional cell coupling and signaling (Gerecht-Nir et al.,
2006).
A small fraction of adult heart cells has stem cell-like
properties (Moretti et al., 2006); however, it is difficult to
isolate and expand these cells in vitro, because of their low
frequency and limited access. Transplantation of exogenous
adult and embryonic stem cells showed improved myocar-
dial function by increasing vascularization and reducing
ventricular remodeling (Orlic et al., 2001; Kehat et al., 2004).
However, these cells may generate immunogenic or tumor-
igenic problems. Breakthroughs resulting in the derivation of
induced pluripotent stem cells (iPS) by the introduction of
four transcription factors (Oct3=4, Sox2, Klf4, and c-Myc) into
adult cells represents a potential way to address this issue
(Takahashi and Yamanaka, 2006; Takahashi et al., 2007), and
may offer a source of autologous functional cardiomyocytes
(Mauritz et al., 2008; Narazaki et al., 2008). It remains to be
determined whether these cells have all the properties of
embryonic stem cells, and how much phenotypic stabiliza-
tion needs to be done in vitro to avoid the risk of teratoma
formation.
A potential alternative approach is that of expanding
nonproliferating primary cardiomyocytes, by step-wise im-
mortalization that requires a combination of immortalization
genes (Hahn et al., 1999), followed by reversal into the ter-
minally differentiated phenotype after the cells are expanded
in culture. The process of reversible immortalization involves
transfer and expression of specific immortalization genes in
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primary cells, and the subsequently removal of these genes
by Cre–loxP site recombination. So far, reversible immortal-
ization had been successfully applied to primary fibroblasts
(Westerman and Leboulch 1996), human muscle satellite
cells (Cudre´-Mauroux et al., 2003), human insulin secreting
beta cells (Narushima et al., 2005), and other types of cells
(Kobayashi et al., 2001; Noguchi et al., 2002; Kowolik et al.,
2004; Hashimoto et al., 2006). Here, we explore whether this
method of gene transfer may be used to expand primary
cardiac cells to numbers that are sufficient for basic research
and regenerative medicine applications. We selected neo-
natal rat cardiomyocytes as model cells because they repre-
sent a widely used ‘‘standard’’ for cardiac tissue engineering
studies. It has been established that neonatal rat cardio-
myocytes undergo terminal differentiation stage during early
neonatal myocardial growth, after which cellular prolifera-
tion no longer occurs (Simpson and Savion, 1982; Long et al.,
1990). For example, the 8-day culture of cell populations
harvested from 1-day-old neonatal rat hearts resulted in a
6-fold increase in numbers of vascular cells and fibroblasts,
and no increase in the number of cardiomyocytes (Long et al.,
1990). This is consistent with our experience in studies of
cardiac tissue engineering using neonatal rat heart cells
(Radisic et al. 2008). We studied reversible immortalization of
primary neonatal rat cardiomyocytes that were (1) immor-
talized by two different combinations of genes (simian virus
40 large T antigen [TAg], or Bmi-1=human telomerase re-
verse transcriptase [hTERT]), (2) expanded in culture, and (3)
reversed back to cardiac phenotype (Fig. 1).
Materials and Methods
Lentiviral vector production
loxP-containing human immunodeficiency virus (HIV)-
derived lentiviral vectors expressing enhanced fluorescent
green protein (GFP), TAg, Bmi-1, and hTERT from an in-
ternal human cytomegalovirus (CMV) immediate promoter
(Salmon et al., 2000) were obtained from Addgene (plasmids
12243, 12246, 12240, and 12245; Addgene, Cambridge, MA).
The recombinant retroviruses were produced by established
methods (Naghavi et al., 2005). In brief, the lentiviral vector
expressing the target gene, the lentiviral packaging construct
(pCMVR8.91) encoding the HIV-1 Gag and Pol precursors,
and the vesicular stomatitis virus (VSV) G envelope con-
struct (pMD.G) (kindly provided by S. Goff, Department of
Microbiology, Columbia University, NY) were cotransfected
into 293T cells in the presence of FuGENE 6 (Roche, Basel,
Switzerland). The culture fluid was harvested 48–72 hr
posttransfection and stored at 808C. The titer of recom-
binant viruses was >5104 transduction units=ml, as de-
termined by flow cytometric analysis of 293T cells or
diluted colonies, counting after selection in hypoxanthine–
aminopterin–thymidine (HAT) medium (Sigma-Aldrich,
St. Louis, MO).
FIG. 1. Experimental design for reversible immortalization of cardiac myocytes. Freshly isolated neonatal rat cardio-
myocytes were preplated for 1 hr and cultured in monolayer, using DMEM supplemented with bromodeoxyuridine (BrdU,
100 mM) for 3–4 days to eliminate fibroblast contamination. The cells were then transduced either with lentiviral vector
expressing simian virus 40 large T antigen (TAg) under the control of the cytomegalovirus (CMV) promoter, or with Bmi-1
vector and then human telomerase reverse transcriptase (hTERT) vector. The transformed cells were subjected to single cell
cloning to yield TAg clone 8 or Bmi-1 clone 4. The cells were then infected with a recombinant adenovirus expressing Cre
recombinase (Ad-CMV-Cre), to remove the TAg, Bmi-1, and hTERT genes that were flanked by loxP sites. Biophysical
stimulation (100 mM phenylephrine [PE], 10 mM norepinephrine [NE], vascular endothelial growth factor [VEGF, 10 ng=ml],
and dickkopf homolog-1 [DKK1, 150 ng=ml]) was applied to the reverted cells.
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Isolation, culture, and transduction of primary neonatal
cardiomyocytes
Primary cultures of neonatal rat ventricular cardio-
myocytes were derived according to previously published
procedures (Radisic et al., 2008). In brief, cardiomyocytes
were obtained from 1- to 2-day-old neonatal Sprague-
Dawley rats by means of a protocol approved by the com-
mittee on animal care at Columbia University (New York,
NY). The ventricles were quartered, dissociated overnight at
48C in a 0.06% (w=v) solution of trypsin in Hanks’ balanced
salt solution (HBSS; GIBCO, Grand Island, NY), washed in
culture medium (Dulbecco’s modified Eagle’s medium
[DMEM] supplemented with 10–20% fetal bovine serum
[FBS], 10mM HEPES, 2mM l-glutamine, and penicillin–
streptomycin [100 units=ml]; GIBCO), and then subjected to a
series of digestions (8min at 378C; 75 rpm) in a 0.1% (w=v)
solution of collagenase type II in HBSS. The harvested cells
were then pooled and resuspended in culture medium. Cells
were preplated for one 60-min period to enrich for cardio-
myocytes. The cells were seeded at a density of 20103
cells=cm2 in 6-well plates. Bromodeoxyuridine (BrdU,
100 mM; Sigma-Aldrich) was added to the growth medium
for 3–4 days to eliminate proliferating fibroblast cells and
progenitor cells (Lokuta et al., 1994; Miragoli et al., 2006).
For transduction, cardiomyocytes were exposed to lenti-
viral vectors at a multiplicity of infection (MOI) of 0.5–2 in
the presence of Polybrene (10mg=ml; Sigma-Aldrich) at 378C
for 6 hr (protocol adapted from Noguchi et al., 2002; Naghavi
et al., 2005). For Bmi-1 and hTERT transduction, the infection
was repeated for 3–4 days. For single cell cloning, 1000
transduced cells were plated on a 100-mm culture dish
coated with methylcellulose-based medium (R&D Systems,
Minneapolis, MN). Colonies were isolated and expanded for
experimentation.
Western blot
Cells were lysed in cell extraction buffer (Invitrogen,
Carlsbad, CA). Total protein from lysate (15mg per sample)
was loaded for sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE) and the proteins were trans-
ferred to nitrocellulose membranes. Membranes were
blocked in 10% milk and incubated with primary antibodies:
mouse monoclonal antibodies against TAg and Bmi-1 (Santa
Cruz Biotechnology, Santa Cruz, CA), and against TERT and
glyceraldehydes-3-phosphate dehydrogenase (GAPDH)
(Abcam, Cambridge, MA) at dilutions of 1:200–1:500, fol-
lowed by secondary antibodies against mouse IgG conju-
gated with horseradish peroxidase (GE Healthcare,
Buckinghamshire, UK). Signal was detected with enhanced
chemiluminescence (ECL) reagent (GE Healthcare).
Measurement of cell growth kinetics
Primary heart cells isolated from neonatal rat were trans-
duced with lentiviral vectors expressing TAg or Bmi-
1=hTERT genes, and their growth kinetics were monitored
by measuring the cell number in each of the first 6–8 pas-
sages of culture in the laboratory. The number of population
doublings at each passage was defined as log N=log 2, where
N is the number of cells harvested at confluence divided by
the number of cells initially seeded. Alternatively, DNA was
measured with a PicoGreen dsDNA kit (Invitrogen) ac-
cording to the manufacturer’s protocol. The cytotoxicity of
adenovirus was tested in a 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay (Sigma-Aldrich).
Reversal to differentiated cell phenotype
Purified adenoviral vector expressing Cre recombinase
under the control of the CMV promoter (Ad-CMV-Cre)
(Vector Biolabs, Philadelphia, PA) was stored at 808C at a
titer of 2107 transduction units=ml. TAg-transduced or
Bmi-1=hTERT-transduced cells were infected with Ad-CMV-
Cre at an MOI of 100–500 for 6–12 hr. The medium was then
replaced with growth medium and the Cre-transduced cells
were continuously cultured for another 4 days and passaged,
to measure the proliferation capability of cells after Ad-
CMV-Cre transduction. For further phenotype characteriza-
tion experiments on the transduced cells after reversal, the
cells were transduced by Ad-CMV-Cre at the required con-
centration (TAg clone 8, MOI: 300; Bmi-1=hTERT clone 4,
MOI: 400) and were maintained in differentiation medium:
DMEM–F12 containing penicillin–streptomycin (100units=ml),
2mM l-glutamine, 5% heat-inactivated FBS, insulin (10mg=ml),
transferrin (5.5mg=ml), and sodium selenite (6.7 ng=ml) (Sigma-
Aldrich) and further supplementedwith 100mM phenylephrine
(PE) and 10mM norepinephrine (NE) (Sigma-Aldrich) or with
vascular endothelial growth factor (VEGF, 10ng=ml)=dickkopf
homolog-1 (DKK1, 150ng=ml; R&D Systems).
Immunofluorescence studies of marker expression
Cells were fixed in 4% paraformaldehyde for 20min at
room temperature, blocked with 10% horse serum (Vector
Biolabs) for 40min at room temperature, and then incubated
for 1 hr at 378C with primary antibodies: mouse anti-cardiac
troponin I (diluted 1:150; Biodesign, Saco, ME), mouse anti-
sarcomeric a-actin (diluted 1:150; Sigma-Aldrich), rabbit anti-
connexin-43 (Cx-43, diluted 1:150; Chemicon, Temecula,
CA), rabbit anti-vimentin (diluted 1:150; Chemicon), and
rabbit anti-Nkx2.5 (diluted 1:50; Santa Cruz Biotechnology)
in phosphate-buffered saline (PBS) containing 0.5% Tween 20
and 1.5% horse serum. Subsequently, the cells were incu-
bated with secondary antibodies: Texas red-conjugated horse
anti-IgG (diluted 1:200; Chemicon) and fluorescein-conju-
gated horse anti-mouse IgG (diluted 1:200; Chemicon). The
nuclei were costained with 40,6-diamidino-2-phenylindole
(DAPI, diluted 1:1000; Vector Biolabs). The images were
captured by fluorescence microscopy (IX81; Olympus,
Tokyo, Japan) and the MetaMorph program (Molecular
Devices, Downingtown, PA). The Matlab program CON-
NEXINMEASUREMENT, developed by our laboratory
(Tandon et al., 2009), was adapted to quantify the presence
of Cx-43 protein. The number of instances of Cx-43 was
measured in n> 40 sections per experimental group, and
normalized by the cell number (measured by counting DAPI-
stained nuclei in the same sections).
Measurements of calcium transients
The excitation–contraction coupling between cells was
evaluated by measuring calcium transients. Briefly, cells
were grown in 35-mm tissue culture dishes for 2–3 days until
70–80% confluent and loaded with 2 mM Fluo-4 (Molecular
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Probes=Invitrogen, Carlsbad, CA) in PBS for 30min at 378C,
washed with PBS, and incubated in growth medium for
another 30min to allow complete deesterification of intra-
cellular acetoxymethyl ester (AM). Last, the cells were loaded
with pulsing buffer containing 255mM sucrose, 1mM CaCl2,
1mMMgCl2, and 5mM HEPES (conductivity, 500mS=cm). A
pair of carbon electrodes (1=8-in. diameter, spaced 3.2 in.
apart; Ladd Research Industries, Williston, VT) was con-
nected to an electrical stimulator (Grass Technologies, West
Warwick, RI) via a platinum wire (Ladd Research Industries)
and placed in the tissue culture chamber. For excitation, field
stimulation was applied at a frequency of 0.3–1Hz, current
pulses of 2 to 100msec in duration, and a signal amplitude of
1–34.2V=cm. Calcium transient images were acquired with a
fluorescence microscope (IX81; Olympus), stored, and ana-
lyzed digitally with the ImageJ program (National Institutes
of Health, Bethesda, MD). For each image, fluorescence in-
tensity was integrated over the entire cell culture space and
corrected by subtracting the background fluorescence mea-




Cardiomyocytes isolated from neonatal rat left ventricles
were treated with BrdU (100mM), a mitotic inhibitor, which
binds to the newly synthesized DNA during the S phase of the
cell cycle, substituting for thymidine during DNA replication.
A high concentration of BrdU in vitro effectively blocked the
proliferation of dividing cells (see Supplementary Fig. 2 at
www.liebertonline.com=hum), including fibroblasts and pro-
genitor cells, presumably because of activation of classical
apoptosis pathways in BrdU-incorporating cells (Xia et al.,
1995; Caldwell et al., 2005). After BrdU incorporation, the
cardiac fibroblasts could not be passaged (Lokuta et al., 1994;
Miragoli et al., 2006) or transduced by lentivirus-mediated
TAg or Bmi-1=hTERT transfection. Likewise, we were not able
to produce any clones from the BrdU-treated fibroblasts.
Approximately 10–20% of the purified cardiomyocytes
exposed to lentiviral vector expressing GFP from the CMV
promoter at an MOI of 2 were transduced (see Supplemen-
tary Fig. 1C at www.liebertonline.com=hum). By the same
cell preparation protocol, DNAs encoding TAg, Bmi-1,
hTERT were introduced by lentivector-mediated transduc-
tion into cardiomyocytes, either alone or in combinations.
Insertion of the gene was confirmed by Western blot analysis
of the expressed protein (Fig. 2).
Cells quickly responded to TAg gene by increased cell
proliferation, within 1–2 weeks of transduction. In contrast,
cells transduced with Bmi-1=hTERT exhibited a significant
delay before starting to form stabilized proliferative clones
(Fig. 3). The delaywas probably due to the lowBmi-1-induced
immortalization frequency (Hashimoto et al., 2006) and slow
cell proliferation rate in the single cell cloning process.
Therefore, we repeatedly transduced cells with Bmi-1 vector
(three or four times), followed by transduction of hTERT three
or four times to increase the immortalization frequency
(protocol adapted from Noguchi et al., 2002; Kowolik et al.,
2004). Without hTERT transduction, Bmi-1-transformed cells
undergo replicative senescence within five passages. With
only hTERT, primary cardiomyocytes cannot be transduced,
FIG. 2. Western blot analysis of lentiviral vectors. Expression of TAg and Bmi-1 followed by hTERT in infected cells was
determined before and after Cre expression. (a) Lane 1, TAg clone 8 cells (passage 11) after Cre expression; lanes 2 and 3, TAg
clone 8 cells before Cre expression (passage 11 and passage 3, respectively). (b) Lane 1, Bmi-1=hTERT clone 4 cells (passage 8)
after Cre expression; lane 2, Bmi-1=hTERT clone 4 cells before Cre expression.
FIG. 3. Proliferation of immortalized cardiomyocytes. The
proliferation of cardiac myocytes transduced with TAg or
with Bmi-1=hTERT in the first six to eight passages of culture
in the laboratory. Cell growth kinetics were monitored by
measuring accumulated population doublings. Cell culture
medium was DMEM supplemented with 10% FBS, 10mM
HEPES, 2mM l-glutamine, and penicillin–streptomycin
(100U=ml).
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as evidenced by the lack of clone induction with up to five
rounds of transfection in multiple experiments.
The average doubling time of TAg-containing cells (TAg
clone 8) was 0.98 days, whereas the average doubling time of
Bmi-1=hTERT-containing cells (Bmi-1=hTERT clone 4) was
3.84 days (Fig. 3). When cells were seeded at a higher density
of 104 cells=cm2 and cultured in growth medium containing
20% FBS, the doubling time fell to 2.5 days for Bmi-1=hTERT-
transduced cells (Bmi-1=hTERT clone 4). TAg-transduced
cells had more compact cell morphology, a lower tendency to
align or flatten (Fig. 4), and tended to form nodules, whereas
Bmi-1=hTERT-transduced cells maintained contact inhibition
and did not grow on top of each other.
Remarkably, some of the Bmi-1=hTERT-transduced cells
maintained contractile activity until passage 3 or 4. When the
derived cells were seeded at low density onto methylcellulose-
coated plates, they proliferated and formed well-defined col-
onies. In total, 28 clones of TAg-transduced cells and 7 clones
of Bmi-1=hTERT-transduced cells were isolated. None of the
colonies showed contractile activity beyond passage 3 or 4.
We scanned all the clones on the basis of immunostaining (Cx-
43, a-actin, and vimentin) and morphology, and then selected
the best clones, TAg clone 8 and Bmi-1=hTERT clone 4, for in-
depth analysis.
Reversal of cell immortalization after Cre recombinase
expression
Both TAg- and Bmi-1=hTERT-transduced cells proliferated
without apparent senescence for more than 6 months of
culture. To totally reverse the immortalization by Cre–loxP
site recombination, we tested the infection of the transduced
cells with adenovirus expressing Cre recombinase (Ad-CMV-
Cre) at various concentrations (MOI, 100–500). Only at a
high concentration (TAg clone 8, MOI 300; Bmi-1=hTERT
clone 4, MOI: 400) of Ad-CMV-Cre transduction did cell
proliferation completely cease for the duration of the study
(Fig. 5). The high MOI adenovirus transduction was proba-
bly due to the limited expression of certain interaction re-
ceptors on the transduced cell surface, such as coxsackievirus
and adenovirus receptor (CAR) (Li et al., 1999) and heparan
sulfate proteoglycans (HSPGs) (Fender et al., 2008). The re-
moval of immortalization genes from the cellular genome
was confirmed by Western blot (Fig. 2). After 6 hr of incu-
bation with adenoviral vector Ad-CMV-Cre, the bioactivity
of control cells (nontransduced cells) was reduced by 12.30%
(MOI, 300) or 35.71% (MOI, 400) by MTT measurement.
Phenotype characterization of transduced cells
before and after reversal
Immunofluorescence analysis of transduced cells showed
expression of a-actin, a prototypical Z-line protein in cardio-
FIG. 4. Cell morphology. (A) TAg-
transduced cells on day 7. (B) TAg clone
8 cells. (C) Bmi-1=hTERT-transduced cells
on day 13. (D) Bmi-1=hTERT clone 4 cells.
Cells immortalized with Bmi-1 and hTERT
appeared large and elongated, whereas
TAg-containing cells were smaller in size
and more rounded in shape. Scale bars:
100 mm.
FIG. 5. Effect of multiplicity of infection (MOI) on cell
proliferation. Cells were harvested, counted, and passaged 4
days after Cre transduction. Baseline: initial seeding cell
number. After high-dose Cre transduction (MOI, 300 for TAg
clone 8; MOI, 400 for Bmi-1=hTERT clone 4), the transfected
cells stopped growing as confirmed by lack of proliferation
in the next passage. Data are shown as averages SD (n¼ 4).
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myocytes, and Cx-43, a connexin gap junction protein in
cardiac muscles (Fig. 6). TAg clone 8 cells exhibited normal
patterns of Cx-43 expression in cell junctions, whereas Bmi-
1=hTERT clone 4 cells did not exhibit these cardiac-specific
patterns. Both clones had low expression of troponin I, a
regulatory protein for cardiac muscle contraction; low ex-
pression of Nkx2.5, a transcription factor related to cardiac
differentiation; and high expression of vimentin, which was
consistent with the dedifferentiation of cells during trans-
formation (LaFramboise et al., 2007; Nakamura et al., 2008).
Both clones maintained Cx-43 and a-actin expression; how-
ever, only TAg clone 8 exhibited localized Cx-43 expression
in cell–cell junctions.
We tested a group of biochemical simulation factors in-
cluding 100mM PE and 10mM NE, and growth factors in-
cluding VEGF (10 ng=ml) and DKK1 (150 ng=ml), on
postexpansion differentiation. Cx-43 quantification, using a
Matlab program (Tandon et al., 2009), showed that the fre-
quency of Cx-43 in primary cardiomyocytes (2.87 per cell)
decreased after TAg-induced transformation (to 1.52 per cell)
and then increased again after Cre recombinase reversion (to
1.62 per cell) as well as after stimulation with PE (to 1.72 per
cell) and growth factors DKK1 and VEGF (to 2 per cell).
Growth factor stimulation and NE also led to increases in a-
actin and Cx-43 in Bmi-1=hTERT-transduced cells after re-
version (Fig. 7); however, these stimulations still could not
generate well-developed cardiac-specific patterned Cx-43.
Spontaneous and induced calcium transients
in immortalized cells
Primary cardiomyocytes exhibited spontaneous contrac-
tions associated with calcium transients, with the fastest
transient rate observed at a frequency of 2Hz, which is in the
physiologic range for rats (Fig. 8A). When contractile func-
tion was induced by electrical stimulation, primary cardio-
myocytes showed excitable calcium transients in a relatively
lower electrical field (20V=cm) and short pulse duration
(2msec), with capture rates of up to 1Hz. TAg clone 8 cells
also exhibit spontaneous calcium transients at much lower
frequency (<0.2Hz), and they could only be excited at lower
frequency (0.3Hz) with a higher electrical field (34.2V=cm)
and longer pulse duration (100msec) (Fig. 8B). Bmi-1=hTERT
clone 4 cells were quiescent and did not undergo any
FIG. 6. Phenotypic characterization of transduced cardiomyocytes. (A–C) Cx-43 (FITC) and a-actin (Texas red) staining of
(A) primary cardiomyocytes, (B) TAg clone 8 cells, and (C) Bmi-1=hTERT clone 4 cells. (D–F) Troponin (FITC) and vimentin
(Texas red) staining of (D) primary cardiomyocytes, (E) TAg clone 8 cells and (F) Bmi-1=hTERT clone 4 cells. (G–I) Nkx2.5
(FITC) staining of (G) primary cardiomyocytes, (H) TAg clone 8 cells, and (I) Bmi-1=hTERT clone 4 cells. (J–K) Isotype
controls for (J) primary cardiomyocytes, (K) TAg clone 8 cells, and (L) Bmi-1=hTERT clone 4 cells. Scale bars: 50 mm. Color
images available online at www.liebertonline.com=hum.
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apparent changes in calcium content, when given the same
stimulation as TAg clone 8 cells (Fig. 8C).
After Cre transduction, the reverted TAg-transduced cells
showed increased spontaneous calcium transients at a fre-
quency of 1Hz (VEGF and DKK1 treatment; Fig. 8B) or
*0.25Hz (NE, PE, or Cre only; see Supplementary Fig. 3E,
G, and C at www.liebertonline.com=hum). With electrical
stimulation at 34.2V=cm and a pulse duration of 100msec,
all reverted TAg-transduced cells could be excited except for
the nontreatment group (Supplementary Fig. 3C, E, G, and I).
After VEGF and DKK1 treatment, reverted TAg-transduced
cells exhibited an increased excitable calcium response fre-
quency up to 1Hz, suggesting enhanced cell excitability after
removing the TAg gene and growth factor stimulation
(Supplementary Fig. 3I). In contrast, after removing the
Bmi-1=hTERT gene, these effects were not seen—the cells
exhibited enhanced spontaneous transients (<0.2Hz) and
increased amplitude of calcium changes, but could not re-
spond to electrical stimulation. After VEGF and DKK1, PE,
or NE treatment, reverted Bmi-1=hTERT-transduced cells
exhibited enhanced spontaneous transients (<0.2Hz), and an
increased amplitude of calcium changes; however, the cells
did not show paced transients in response to electrical
stimulation (Supplementary Fig. 3D, F, H, and J).
Discussion
Our experiments show that reversible immortalization has
the potential to generate large numbers of patient-specific
cells for cardiac tissue engineering. First, we proved lenti-
viral vectors were efficient in introducing genes into primary
cardiomyocytes; approximately 10–20% of the purified pri-
mary cardiomyocytes could be infected with lentiviral vector
at an MOI of 2. The high transduction efficiency of lentiviral
vector was the result of their ability to mediate stable inte-
gration and long-term expression of transgenes in a wide
variety of targets irrespective of their proliferative status
(Salmon et al., 2000). However, potential insertional muta-
genesis may occur through the random integration of in-
serted lentiviral vectors; site-specific insertion by adeno-
associated virus (AAV)-mediated transduction may be a
promising option for future work.
Second, we compared the application of two frequently
used immortalizing genes (Cudre´-Mauroux et al., 2003): TAg,
which acts through the binding of retinoblastoma protein
(Rb) and p53 (Ali and DeCaprio, 2001), and Bmi-1, which
downregulates the p16 and p19Arf tumor suppressor genes
encoded by the ink4a locus ( Jacobs et al., 1999), and is often
combined with human telomerase (hTERT) (Hashimoto et al.,
2006). Lentivector-mediated transduction of TAg alone, or of
Bmi-1=hTERT, resulted in the immortalization of primary
neonatal rat cardiomyocytes such that they acquired the
ability to proliferate over prolonged periods of time (up to
6 months of continuous culture during our studies). In con-
trast, Bmi-1 alone was not able to sustain continuous cell
growth. Consistently, the cell phenotypes associated with the
transduction of these two sets of immortalization genes were
distinctly different. The TAg gene was expressed at high
levels, and induced fast cell proliferation without a lag
phase, which led to cells arranged in colonies and round in
FIG. 7. Phenotypic characterization of reverted clones after Cre transduction. (A–C) Cx-43 (FITC) and a-actin (Texas red)
staining of TAg clone 8 cells after Cre transduction (A), TAg clone 8 cells after Cre transduction and PE stimulation (B), and
TAg clone 8 cells after Cre transduction and GF stimulation (C). (D–F) Cx-43 (FITC) and a-actin (Texas red) staining of Bmi-
1=hTERT clone 4 cells after Cre transduction (D), Bmi-1=hTERT clone 4 cells after Cre transduction and NE stimulation (E),
and Bmi-1=hTERT clone 4 cells after Cre transduction and GF stimulation (F). PE, phenylephrine (100 mM); NE, norepi-
nephrine (10 mM); GF, VEGF (10 ng=ml) and DKK1 (150 ng=ml). Scale bars: 50 mm. Color images available online at
www.liebertonline.com=hum.
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shape, aggregating and growing without contact inhibition
in most clones. In contrast, Bmi-1=hTERT transduction
delayed cell proliferation, which occurred at a much slower
rate, and Bmi-1=hTERT-transduced cells exhibited more ex-
tended cell morphology, and maintained the contact inhibi-
tion growth pattern in all clones, which was possibly due to
the low levels of gene expression. The method established in
this study enabled us to start with a small number of primary
cells (<600,000), transform the cells, and derive stable TAg-
transduced clones within approximately 3 weeks. The
method could potentially be used to derive large numbers of
repair cells from a small biopsy sample, for use in cardiac
therapy.
Interestingly, certain phenotype characteristics of primary
cardiomyocytes (expression of a-actin, patterned Cx-43, and
spontaneous and induced calcium transients) were con-
served through multiple generations of TAg-transduced
cells. In particular, the excitation–contraction coupling mea-
sured as calcium transients showed that the sarcoplasmic
reticulum of TAg clone 8 cells was still able to release calcium
in response to electrical stimulation. The lack of response to
electrical stimulation at higher frequencies may be attributed
to delayed restoration of excitability, because intracellular
calcium in these cells may return to the basal level more
slowly than in primary cardiomyocytes. The presence of
cardiac-specific features in Bmi-1=hTERT-transduced cells
was less evident than in TAg-transduced cells (the expres-
sion of a-actin was conserved, but Cx-43 patterning and
calcium responses were not).
After adenovirus-mediated Cre recombinase expression,
which spliced the inserted genes, we noticed a complete ar-
rest of cell proliferation and increased expression of Cx-43 in
TAg-transduced cells. To redifferentiate cardiac phenotypes
in those reverted cells, we tested a group of biochemical
stimulatory molecules including PE, NE, VEGF, and DKK1.
PE and NE are pharmacologic agents, used in clinics to elicit
varied effects on vascular resistance, myocardial contractil-
ity, and heart rate (Coons and Seidl, 2007). Cellular studies
showed that PE or NE could further induce sarcomere for-
mation in some transformed cardiac cells (Rybkin et al.,
2003). In our studies, the supplementation of culture medium
with PE or NE enhanced the expression of a-actin as well as
Cx-43 in reverted cells. VEGF and DKK1 are growth factors
used in the cardiovascular differentiation of embryonic
stem cells, through stage-specific inhibition of Wnt signaling
(Yang et al., 2008). VEGF and DKK1 enhanced the expression
of a-actin and Cx-43 in both TAg-transduced and Bmi-
1=hTERT-transduced cells after reversion. Stimulation with
VEGF and DKK1 also increased the calcium transient fre-
quency in reverted TAg-transduced cells, suggesting im-
proved capacity of the cells for electrical communication.
Our findings are consistent with the previous findings
that Wnt signaling and VEGF are important modulators of
Cx-43 expression in cardiomyocytes (Ai et al., 2000; Yamada
et al., 2005). Because inappropriate expression of Wnt sig-
naling had been found in a variety of cell transformations
(Smalley and Dale, 1999), we hypothesized that Wnt sig-
naling was triggered during cell immortalization, causing
the loss of some properties of the cardiac phenotype, such
as the decrease in Cx-43. Therefore, modulation of Wnt
signaling with growth factors may present a method to
redifferentiate the cardiac phenotype after reversion. Taken
together, these data suggest that the immortalization of
terminally differentiated cardiac myocytes could have
practical value. Further phenotypic analysis of the cells
in vivo should be included for future study, in order to
better characterize the functional value of the reversible
immortalization of cardiomyocytes.
This study shares some similarities with studies of repro-
grammed (iPS) cells (Mauritz et al., 2008; Narazaki et al.,
FIG. 8. Calcium transients in primary cardiomyocytes and
transduced cells. (A) Spontaneous and paced calcium tran-
sient in primary cells (stimulation: 20V=cm, 1Hz, 2-msec
duration). (B) Spontaneous and paced calcium transient in
TAg clone 8 cells before and after Cre expression with
growth factor treatment. (Before Cre expression, stimulation:
34.2V=cm, 0.3Hz, 100-msec duration; After Cre expression
and growth factor treatment, stimulation 1: 34.2V=cm,
0.3Hz, 100-msec duration; stimulation 2: 34.2V=cm, 1Hz,
2-msec duration). (C) Spontaneous and paced calcium tran-
sient in Bmi-1=hTERT clone 4 cells before and after Cre
expression with growth factor treatment (stimulation:
34.2V=cm, 0.3Hz, 100-msec duration). Color images avail-
able online at www.liebertonline.com=hum.
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2008). Both strategies use lentivirus-based gene transduction
to induce adult primary cells into dedifferentiated prolifer-
ating status, and apply growth factors to redifferentiate the
expanded cells into specific lineages. Notably, when revers-
ible immortalization is used, the expanded cells are depleted
of the inserted genes via loxP–Cre recombination. As a result
of complete gene splicing, cell proliferation was completely
arrested, enabling the elimination of potential tumorigenic
problems in transplantation practice.
The iPS research suggested various strategies of gene
transfer toward deriving fully functional, mature cell phe-
notypes. The TAg gene interacts with cell cycling-related
factors, such as p53 (Schultz et al., 2000), which induces cell
proliferation, but is also involved in the control of DNA re-
pair and recombination. In iPS studies, differentiated cell
phenotypes are derived through a series of steps starting
with early cell differentiation. In studies of reversible im-
mortalization, the process is being shortened by picking the
most ‘‘promising’’ clones that express specific key pheno-
types and by regaining the lost cell phenotypes by proper
stimulation after gene splicing. This ‘‘shortcut’’ strategy
worked well with many cell types, such as human insulin-
secreting beta cells (Narushima et al., 2005). If, however, the
full phenotypic characteristics of cardiomyocytes are not re-
stored (in particular, the contractile function), we may need
to implement some of the strategies used to derive iPS cells.
In summary, the strategy for controlled expansion of pri-
mary cardiomyocytes by gene transfer has the potential to
provide large amounts of a patient’s own cardiomyocytes for
cell therapy. Further studies are needed to determine whe-
ther the phenotypic properties of reversed cells are sufficient
for cell therapy of the heart. In turn, because of the partial
expression of the cardiac phenotype, these cells could serve
as an interesting model for studies of cardiac differentiation.
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